Tag: cirrhosis

MR Elastography Could Predict Cirrhosis in NAFLD

Liver stiffness measurement with magnetic resonance elastography (MRE) may prove predictive of future cirrhosis risk in patients with nonalcoholic fatty liver disease (NAFLD), according to...

Novel Liver Dialysis Device May Safely Curb ACLF

An investigational liver dialysis device (DIALIVE) was associated with significantly greater survival of patients with acute-on-chronic liver failure (ACLF), compared with the standard of care...

Calories May Outweigh Nutrients in Diets for Fatty Liver

Intermittent calorie restriction offers only modest advantages over a low-carbohydrate, high-fat diet (LCHF) for treating nonalcoholic fatty liver disease (NAFLD), researchers say. The intermittent diet...

Do Anti-ApoA-1 Antibodies Link Fatty Liver Disease and CVD?

Anti-apolipoprotein A-1 (ApoA-1) antibodies are common in non-alcoholic fatty liver disease (NAFLD) and may not only drive its development but also underlie the link between...

FDA Restricts Obeticholic Acid Over Serious Liver Injury Risk

The risk for serious liver injury with obeticholic acid (Ocaliva, Intercept Pharmaceuticals) has prompted the US Food and Drug Administration (FDA) to restrict its use...

Bariatric Surgery May Cut Cancer in Obesity With Liver Disease

In a large cohort of insured working adults with severe obesity and nonalcoholic fatty liver disease (NAFLD), among those who underwent bariatric surgery, the rate of...

Hepatotoxicity Risk Differs Between Psoriasis, PsA, and RA Patients

Patients taking methotrexate for psoriasis or psoriatic arthritis (PsA) were at a higher risk of developing liver disease than were patients with rheumatoid arthritis (RA)...

AASLD 2020: A Clinical News Roundup

Studies that address fundamental questions in hepatology and have the potential to change or improve clinical practice were the focus of a clinical debrief session...

Trio Awarded Nobel Prize in Medicine for Discovering Hep C Virus

The Nobel Prize in Physiology or Medicine was awarded to two Americans and a British-born scientist this morning for the discovery of the hepatitis C...

Hepatocellular Carcinoma Shows Risk Factor Shift

Rates of hepatocellular carcinoma (HCC) continue to rise in the United States, but unevenly so given how the incidence has become highest in the Hispanic...

Fecal Transplant Shows Promise in Reducing Alcohol Craving

Fecal microbiota transplantation results in a short-term reduction in alcohol craving in patients with alcohol-induced cirrhosis who can’t stop drinking, results from a new study...

Terlipressin Squeaks by FDA Review for Hepatorenal Syndrome 1

The US Food and Drug Administration’s (FDA’s) Cardiovascular and Renal Drugs Advisory Committee narrowly recommended, by an 8-7 vote, that the agency grant marketing approval...

COMMENTARY: Treating Liver Disease During COVID-19: New Recommendations

What your doctor is reading on Medscape.com: MAY 14, 2020 — The COVID-19 pandemic presents myriad challenges to hepatologists, gastroenterologists, transplant programs, primary...